uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Accumulated Expenses (2015 - 2026)

uniQure (QURE) posted quarterly Accumulated Expenses of $51.1 million for Q2 2026, up 62.44% year-over-year from $31.5 million in Q2 2025, and up 18.36% quarter-over-quarter from $43.2 million in Q1 2026.

Analysis

uniQure (QURE) Accumulated Expenses (2015 - 2026) Analysis & Trends

uniQure's Accumulated Expenses history runs 12 years deep, the most recent figure standing at $51.1 million for Q2 2026.

  • In Q2 2026, Accumulated Expenses rose 62.44% year-over-year to $51.1 million; the TTM figure through Jun 2026 stood at $51.1 million (up 62.44% YoY), while the FY2025 annual figure was $41.3 million, up 41.29% from the prior year.
  • Accumulated Expenses for Q2 2026 stood at $51.1 million, up from $43.2 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $51.9 million in Q3 2025, with the low at $1.4 million in Q4 2023.
  • The 5-year median for Accumulated Expenses is $27.9 million (2023), against an average of $29.6 million.
  • The sharpest annual moves came in 2023 and 2024: Accumulated Expenses slumped 95.42% in 2023, then jumped 1987.5% in 2024.
  • uniQure's Accumulated Expenses stood at $30.6 million in 2022, then plunged by 95.42% to $1.4 million in 2023, then surged by 1987.5% to $29.2 million in 2024, then surged by 41.29% to $41.3 million in 2025, then advanced by 23.83% to $51.1 million in 2026.
  • Business Quant data shows QURE's Accumulated Expenses at $51.1 million in Q2 2026, $43.2 million in Q1 2026, and $41.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.13 Mn
Mar 31, 2026 43.20 Mn
Dec 31, 2025 41.29 Mn
Sep 30, 2025 51.95 Mn
Jun 30, 2025 31.48 Mn
Mar 31, 2025 27.34 Mn
Dec 31, 2024 29.23 Mn
Sep 30, 2024 32.30 Mn
Jun 30, 2024 26.49 Mn
Mar 31, 2024 22.66 Mn
Dec 31, 2023 30.53 Mn
Sep 30, 2023 28.43 Mn
Jun 30, 2023 23.54 Mn
Mar 31, 2023 22.53 Mn
Dec 31, 2022 30.57 Mn
Sep 30, 2022 26.44 Mn
Jun 30, 2022 23.05 Mn
Mar 31, 2022 19.95 Mn
Dec 31, 2021 28.49 Mn
Sep 30, 2021 30.75 Mn